FDA panel recommends Aimmune's peanut allergy treatment

CNBC's Meg Tirrell joins "Closing Bell" to report the latest decision from an outside adivsory panel to the FDA voting in favor of what could be the first-approved peanut allergy treatment from Aimmune Therapeutics.
00:44
Fri, Sep 13 20194:43 PM EST